Filing Flows › Comparisons › PSNL vs XGN
Personalis vs Exagen: PSNL and XGN compared
Personalis is the larger company: $25.6M of revenue in its latest quarter (Q3 2026) against $19.9M for Exagen (Q2 2026). Personalis is growing faster (+77% against +16% a year earlier). Exagen is more profitable, with an operating margin of -8.6% against -138.8%.
Where the money goes: PSNL and XGN
Personalis (PSNL) · Q3 2026
Personalis, Q3 2026: revenue $25.6M (+77% year over year), operating margin -138.8%, net loss $33.8M, operating cash flow −$27.1M. The chart follows the revenue to costs, profit and cash.
Exagen (XGN) · Q2 2026
Exagen, Q2 2026: revenue $19.9M (+16% year over year), operating margin -8.6%, net loss $3.2M, operating cash flow $4.0M. The chart follows the revenue to costs, profit and cash.
| Personalis (PSNL) | Exagen (XGN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $25.6M | $19.9M |
| Revenue growth, Y/Y | +77% | +16% |
| Operating margin | -138.8% | -8.6% |
| Net earnings | −$33.8M | −$3.2M |
| Net margin | -132.1% | -16.0% |
| Operating cash flow | −$27.1M | $4.0M |
| Free cash flow | — | $3.4M |
Questions
Which is bigger, Personalis or Exagen?
Personalis is the larger company: $25.6M of revenue in its latest quarter (Q3 2026) against $19.9M for Exagen (Q2 2026).
Is Personalis or Exagen growing faster?
Personalis is growing faster (+77% against +16% a year earlier).
Which is more profitable, Personalis or Exagen?
Exagen is more profitable, with an operating margin of -8.6% against -138.8%.
More: Personalis earnings · how Personalis makes money · Exagen earnings · how Exagen makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 4, 2026). Fiscal quarters can end on different dates. Not investment advice.